All Insights
Showing 1 - 12 of 420
Life Sciences and Healthcare
Autumn Budget 2025: what does recent government policy mean for UK life sciences and healthcare?
Targeted R&D support and faster regulatory pathways will be boosted by landmark UK-US pharmaceuticals deal
Regulatory Outlook
Artificial intelligence | UK Regulatory Outlook November 2025
UK: Landmark UK AI and IP case: Getty Images v Stability AI | Select Committee opens inquiry on AI and
Life Sciences and Healthcare
Implications of the German GEMA ./. OpenAI judgment on the Life Sciences and Healthcare Sector
The District Court of Munich I has issued a landmark ruling on copyright infringement involving AI (11 November 2025, case
Intellectual property
English Court of Appeal limits use of interim FRAND licence declarations in SEP disputes
The court distinguished previous case law and provided guidance on what amounts to acting in bad faith in FRAND proceedings
Intellectual property
Munich court grants Germany's first pan-EU cross-border patent injunction post-BSH v Electrolux
Munich Regional Court relied on BSH v Electrolux to injunct Formycon's aflibercept formulation in 22 countries based on doctrine of
Intellectual property
The Green Deal vs green claims: guidance within the EU regulatory framework against greenwashing
Often mentioned in connection with politics and climate protection, it is not always clear what lies behind these terms.
Artificial intelligence
Getty v Stability AI: Stability AI generates big win in English court's landmark first judgment on AI and IP infringement
Getty's secondary copyright infringement claim dismissed as Stable Diffusion found not to contain any of Getty's copyright works
Unified Patent Court
UPC grants first anti-interim-licence injunction in SEP dispute; English court responds with anti-anti-suit relief
Mannheim LD granted provisional measures to prevent Amazon seeking interim-licence declarations in English courts
Unified Patent Court
UPC flexes long-arm jurisdiction again by granting permanent injunction covering non-UPC and non-EU states
The Hague LD made inter partes validity findings in relation to non-EU patent designations
Unified Patent Court
Life sciences at the fore of preliminary injunction trends emerging from Europe's UPC
Half of PIs granted at first instance on inter partes basis, with invalidity and non-infringement main points of refusal
Intellectual property
Getty Images v Stability AI: a landmark trial for generative AI in UK?
With judgment day in the offing, the issues raised in the case will help craft the UK landscape for AI
